These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9386054)

  • 21. Extra-esophageal disorders in gastroesophageal reflux disease.
    Jaspersen D
    Dig Dis; 2004; 22(2):115-9. PubMed ID: 15383751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot study of the oral omeprazole test for reflux laryngitis.
    Metz DC; Childs ML; Ruiz C; Weinstein GS
    Otolaryngol Head Neck Surg; 1997 Jan; 116(1):41-6. PubMed ID: 9018256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of omeprazole on the course of associated esophagitis and laryngitis.
    Jaspersen D; Weber R; Hammar CH; Draf W
    J Gastroenterol; 1996 Dec; 31(6):765-7. PubMed ID: 9027637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omeprazole for the treatment of posterior laryngitis.
    Leite LP; Johnston BT; Castell DO
    Am J Med; 1995 Dec; 99(6):694-5. PubMed ID: 7503099
    [No Abstract]   [Full Text] [Related]  

  • 25. [Association of gastroesophageal reflux and chronic laryngitis].
    Jaspersen D; Weber R; Hammar CH; Draf W
    Leber Magen Darm; 1995 Sep; 25(5):218-9. PubMed ID: 7500809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of sleep disturbances and gastroesophageal reflux in chronic laryngitis.
    Konermann M; Radü HJ; Teschler H; Rawert B; Heimbucher J; Sanner BM
    Am J Otolaryngol; 2002; 23(1):20-6. PubMed ID: 11791245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silent reflux: ex juvantibus criteria for diagnosis and treatment of laryngeal disorders.
    Monini S; Di Stadio A; Vestri A; Barbara M
    Acta Otolaryngol; 2006 Aug; 126(8):866-71. PubMed ID: 16846931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Modern attitude towards management of laryngopharyngeal form of gastroesophageal reflux disease. Lithuanian clinical practice guidelines for adults].
    Siupsinskiene N; Uloza V; Pribuisiene R; Butkus E; Kupcinskas L
    Medicina (Kaunas); 2007; 43(10):832-9. PubMed ID: 17998802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy.
    Qua CS; Wong CH; Gopala K; Goh KL
    Aliment Pharmacol Ther; 2007 Feb; 25(3):287-95. PubMed ID: 17269990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.
    Lundell L; Miettinen P; Myrvold HE; Pedersen SA; Liedman B; Hatlebakk JG; Julkonen R; Levander K; Carlsson J; Lamm M; Wiklund I
    J Am Coll Surg; 2001 Feb; 192(2):172-9; discussion 179-81. PubMed ID: 11220717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders].
    Issing WJ; Tauber S; Folwaczny C; Reichel O
    Laryngorhinootologie; 2003 May; 82(5):347-52. PubMed ID: 12800080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of salivary pH and volume in adults with chronic laryngopharyngitis by gastroesophageal reflux disease before and after treatment.
    Eckley CA; Costa HO
    Braz J Otorhinolaryngol; 2006; 72(1):55-60. PubMed ID: 16917554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of chronic laryngitis associated with reflux.
    Hanson DG; Jiang JJ
    Am J Med; 2000 Mar; 108 Suppl 4a():112S-119S. PubMed ID: 10718463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pH monitoring in patients with benign voice disorders.
    Grøntved AM; West F
    Acta Otolaryngol Suppl; 2000; 543():229-31. PubMed ID: 10909027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presumed laryngo-pharyngeal reflux: investigate or treat?
    Fraser AG; Morton RP; Gillibrand J
    J Laryngol Otol; 2000 Jun; 114(6):441-7. PubMed ID: 10962677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of antireflux therapy for the treatment of chronic laryngitis.
    Hanson DG; Kamel PL; Kahrilas PJ
    Ann Otol Rhinol Laryngol; 1995 Jul; 104(7):550-5. PubMed ID: 7598368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study.
    Noordzij JP; Khidr A; Evans BA; Desper E; Mittal RK; Reibel JF; Levine PA
    Laryngoscope; 2001 Dec; 111(12):2147-51. PubMed ID: 11802014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of acid suppressive therapy in patients with posterior laryngitis.
    Ulualp SO; Toohill RJ; Shaker R
    Otolaryngol Head Neck Surg; 2001 Jan; 124(1):16-22. PubMed ID: 11228446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proximal esophageal pH-metry in patients with 'reflux laryngitis'.
    Jacob P; Kahrilas PJ; Herzon G
    Gastroenterology; 1991 Feb; 100(2):305-10. PubMed ID: 1985028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors.
    Ortiz A; Martínez de Haro LF; Parrilla P; Molina J; Bermejo J; Munitiz V
    Br J Surg; 1999 Nov; 86(11):1472-4. PubMed ID: 10583299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.